| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,717 |
4,039 |
$237K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,263 |
951 |
$51K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
233 |
196 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
465 |
390 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
253 |
165 |
$13K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
100 |
84 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
75 |
65 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
121 |
101 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
92 |
66 |
$6K |
| 87634 |
|
15 |
14 |
$780.10 |
| 92551 |
|
86 |
83 |
$769.71 |
| 87428 |
|
22 |
12 |
$767.14 |
| 99173 |
|
96 |
83 |
$547.27 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
27 |
26 |
$362.52 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
56 |
12 |
$355.82 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
12 |
$200.54 |
| 96127 |
|
26 |
24 |
$129.70 |
| 85018 |
|
27 |
25 |
$75.06 |
| 36416 |
|
14 |
14 |
$23.80 |
| 96161 |
|
50 |
40 |
$8.56 |
| 90670 |
|
67 |
56 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |
| 3008F |
|
694 |
569 |
$0.00 |
| 90686 |
|
422 |
236 |
$0.00 |
| 90723 |
|
36 |
28 |
$0.00 |
| 90656 |
|
31 |
30 |
$0.00 |
| 90647 |
|
15 |
13 |
$0.00 |